YS Biopharma (YS) Stock Chart & Stock Price History → This military-backed stock “owns” AI market (From Porter & Company) (Ad) Free YS Stock Alerts $0.84 -0.07 (-7.73%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends YS Biopharma Stock Price Performance5 Day Performance-18.14%1 Month Performance+11.33%3 Month Performance+94.64%6 Month Performance+57.52%Year-To-Date Performance+63.41%1 Year Performance-50.00% Receive YS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Behind the Markets“This will be one of the biggest revolutions ever.” - NVIDIA CEONVIDIA's CEO calls it the "next amazing revolution"... The Economist says its a "boon to humanity"... And Jeff Bezos is heavily invested in it.A new breakthrough tech could add up to $20 trillion to the U.S. economy. YS Stock Chart for Saturday, June, 1, 2024 YS Chart by TradingView YS Biopharma Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$0.93$0.84-10.22%$0.88$0.8068,518 shs$77.71 million05/30/2024$0.93$0.93$1.01$0.9246,987 shs$86.55 million05/29/2024$1.02$0.93-8.82%$1.01$0.9246,645 shs$86.55 million05/28/2024$1.02$1.02$1.10$0.90107,200 shs$94.92 million05/27/2024$1.02$1.02$1.10$0.90107,200 shs$94.92 million05/24/2024$0.93$1.02+9.68%$1.10$0.90102,959 shs$94.92 million Get the Latest News and Ratings for YS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$0.92$0.93+1.21%$0.94$0.8832,797 shs$86.55 million05/22/2024$0.98$0.92-6.23%$0.98$0.8836,115 shs$85.51 million05/21/2024$0.96$0.98+2.08%$1.00$0.9563,940 shs$91.20 million05/20/2024$0.98$0.96-1.83%$1.00$0.9350,894 shs$89.34 million05/17/2024$0.95$0.98+2.94%$1.03$0.9562,327 shs$91.00 million05/16/2024$1.03$0.95-7.77%$1.02$0.9544,078 shs$88.41 million05/15/2024$0.99$1.03+4.24%$1.03$0.9072,261 shs$95.85 million05/14/2024$0.90$0.99+9.78%$1.01$0.9473,586 shs$91.95 million05/13/2024$0.97$0.90-7.21%$1.01$0.81106,962 shs$83.76 million05/10/2024$0.95$0.97+1.89%$0.99$0.90170,130 shs$90.27 million05/09/2024$0.95$0.95+0.21%$1.02$0.94299,070 shs$88.59 million05/08/2024$0.78$0.95+21.79%$0.95$0.85206,144 shs$88.41 million05/07/2024$0.77$0.78+0.97%$0.82$0.7227,529 shs$72.59 million05/06/2024$0.74$0.77+4.70%$0.81$0.7334,180 shs$71.89 million05/03/2024$0.74$0.74-0.03%$0.77$0.7214,831 shs$68.66 million05/02/2024$0.75$0.74-1.60%$0.75$0.7025,309 shs$68.68 million05/01/2024$0.73$0.75+3.31%$0.77$0.7140,632 shs$69.80 million04/30/2024$0.77$0.73-5.71%$0.78$0.7054,115 shs$67.56 million04/29/2024$0.80$0.77-3.75%$0.84$0.7576,029 shs$71.66 million04/26/2024$0.80$0.80+0.63%$0.85$0.7739,764 shs$74.45 million04/25/2024$0.81$0.80-1.85%$0.85$0.7169,079 shs$73.98 million04/24/2024$0.81$0.81-0.11%$0.82$0.8024,318 shs$75.38 million04/23/2024$0.74$0.81+9.43%$0.82$0.7755,155 shs$75.46 million04/22/2024$0.73$0.74+2.15%$0.81$0.7187,203 shs$68.96 million04/19/2024$0.86$0.73-15.16%$0.88$0.70417,780 shs$67.51 million04/18/2024$0.94$0.86-8.65%$0.96$0.83354,272 shs$79.57 million04/17/2024$0.85$0.94+9.63%$0.96$0.80413,726 shs$87.10 million04/16/2024$0.89$0.85-4.07%$0.88$0.8345,905 shs$79.46 million04/15/2024$0.86$0.89+3.49%$0.92$0.83112,869 shs$82.82 million04/12/2024$0.86$0.86-0.57%$0.93$0.8356,970 shs$80.03 million04/11/2024$0.90$0.86-3.90%$0.93$0.8368,918 shs$80.49 million04/10/2024$0.85$0.90+5.88%$0.91$0.8299,053 shs$83.75 million04/09/2024$0.88$0.85-3.41%$0.90$0.83487,406 shs$79.10 million04/08/2024$0.88$0.88-0.19%$0.99$0.8553,649 shs$81.89 millionThe only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.04/05/2024$0.90$0.88-1.82%$0.95$0.8758,811 shs$82.05 million04/04/2024$0.84$0.90+6.65%$1.02$0.82499,241 shs$83.57 million04/03/2024$0.75$0.84+12.42%$0.85$0.75261,191 shs$78.36 million04/02/2024$0.73$0.75+3.31%$0.78$0.7178,434 shs$69.70 million04/01/2024$0.72$0.73+0.71%$0.78$0.70108,244 shs$67.47 million03/29/2024$0.72$0.72$0.73$0.6649,864 shs$66.99 million03/28/2024$0.71$0.72+1.39%$0.73$0.6649,501 shs$66.99 million03/27/2024$0.63$0.71+12.70%$0.77$0.60135,276 shs$66.07 million03/26/2024$0.65$0.63-3.08%$0.67$0.58245,636 shs$58.63 million03/25/2024$0.63$0.65+3.17%$0.66$0.6319,942 shs$60.49 million03/22/2024$0.63$0.63+0.57%$0.66$0.6199,720 shs$58.63 million03/21/2024$0.63$0.63-0.57%$0.70$0.62158,401 shs$58.29 million03/20/2024$0.64$0.63-0.80%$0.67$0.61110,933 shs$58.63 million03/19/2024$0.72$0.64-11.31%$0.71$0.61163,557 shs$59.10 million03/18/2024$0.72$0.72-0.95%$0.76$0.70241,828 shs$66.64 million03/15/2024$0.71$0.72+2.55%$0.75$0.6868,846 shs$67.28 million03/14/2024$0.74$0.71-4.73%$0.78$0.68188,229 shs$65.61 million03/13/2024$0.68$0.74+9.45%$0.82$0.71312,709 shs$68.86 million03/12/2024$0.64$0.68+5.81%$0.79$0.57371,666 shs$62.92 million03/11/2024$0.63$0.64+1.75%$0.68$0.61122,261 shs$59.47 million03/08/2024$0.61$0.63+2.97%$0.64$0.6150,415 shs$58.44 million03/07/2024$0.64$0.61-4.55%$0.63$0.55228,413 shs$56.76 million03/06/2024$0.61$0.64+4.75%$0.72$0.55850,023 shs$59.47 million03/05/2024$0.46$0.61+32.46%$0.65$0.44699,469 shs$56.77 million03/04/2024$0.43$0.46+7.34%$0.46$0.42177,939 shs$42.85 million03/01/2024$0.38$0.43+12.89%$0.43$0.38765,771 shs$39.92 million02/29/2024$0.38$0.38$0.40$0.3874,744 shs$35.36 million Related Companies: FibroBiologics Stock Chart Verrica Pharmaceuticals Stock Chart Shattuck Labs Stock Chart AC Immune Stock Chart Organogenesis Stock Chart Amarin Stock Chart Alto Neuroscience Stock Chart Precigen Stock Chart Skye Bioscience Stock Chart Silverback Therapeutics Stock Chart Receive YS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for YS Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:YS) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersDems have chosen Biden replacement?Paradigm PressTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.